HY-109041-5mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-50mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mL
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-124756-1mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-10mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-100mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-25mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-5mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-50mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-1mL
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-110177-10mg
|
MedChemexpress LLC
|
SP-100030 [CAS 154563-54-9]
|
|
COVID-19-immunoregulation
|
|
HY-110177-100mg
|
MedChemexpress LLC
|
SP-100030 [CAS 154563-54-9]
|
|
COVID-19-immunoregulation
|
|
HY-110177-25mg
|
MedChemexpress LLC
|
SP-100030 [CAS 154563-54-9]
|
|
COVID-19-immunoregulation
|
|
HY-110177-5mg
|
MedChemexpress LLC
|
SP-100030 [CAS 154563-54-9]
|
|
COVID-19-immunoregulation
|
|
HY-110177-50mg
|
MedChemexpress LLC
|
SP-100030 [CAS 154563-54-9]
|
|
COVID-19-immunoregulation
|
|
HY-110177-1mL
|
MedChemexpress LLC
|
SP-100030 [CAS 154563-54-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-15870-1mg
|
MedChemexpress LLC
|
SR 11302 [CAS 160162-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15870-10mg
|
MedChemexpress LLC
|
SR 11302 [CAS 160162-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15870-100mg
|
MedChemexpress LLC
|
SR 11302 [CAS 160162-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15870-5mg
|
MedChemexpress LLC
|
SR 11302 [CAS 160162-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15870-50mg
|
MedChemexpress LLC
|
SR 11302 [CAS 160162-42-5]
|
|
COVID-19-immunoregulation
|
|
HY-15870-1mL
|
MedChemexpress LLC
|
SR 11302 [CAS 160162-42-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-13756A-10mg
|
MedChemexpress LLC
|
TacroliMu s (monohydrate) [CAS 109581-93-3]
|
|
COVID-19-immunoregulation
|
|
HY-13756A-5mg
|
MedChemexpress LLC
|
TacroliMu s (monohydrate) [CAS 109581-93-3]
|
|
COVID-19-immunoregulation
|
|
HY-13756A-50mg
|
MedChemexpress LLC
|
TacroliMu s (monohydrate) [CAS 109581-93-3]
|
|
COVID-19-immunoregulation
|
|